vs

Side-by-side financial comparison of Aterian, Inc. (ATER) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $15.1M, roughly 1.4× Aterian, Inc.). Aterian, Inc. runs the higher net margin — -52.5% vs -165.4%, a 112.9% gap on every dollar of revenue. On growth, NEKTAR THERAPEUTICS posted the faster year-over-year revenue change (-25.3% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-65.0M). Over the past eight quarters, NEKTAR THERAPEUTICS's revenue compounded faster (0.4% CAGR vs -13.5%).

Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

ATER vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.4× larger
NKTR
$21.8M
$15.1M
ATER
Growing faster (revenue YoY)
NKTR
NKTR
+13.3% gap
NKTR
-25.3%
-38.5%
ATER
Higher net margin
ATER
ATER
112.9% more per $
ATER
-52.5%
-165.4%
NKTR
More free cash flow
ATER
ATER
$63.9M more FCF
ATER
$-1.0M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
NKTR
NKTR
Annualised
NKTR
0.4%
-13.5%
ATER

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATER
ATER
NKTR
NKTR
Revenue
$15.1M
$21.8M
Net Profit
$-7.9M
$-36.1M
Gross Margin
56.1%
Operating Margin
-51.1%
-126.9%
Net Margin
-52.5%
-165.4%
Revenue YoY
-38.5%
-25.3%
Net Profit YoY
-512.2%
-596.9%
EPS (diluted)
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATER
ATER
NKTR
NKTR
Q4 25
$15.1M
$21.8M
Q3 25
$19.0M
$11.8M
Q2 25
$19.5M
$11.2M
Q1 25
$15.4M
$10.5M
Q4 24
$24.6M
$29.2M
Q3 24
$26.2M
$24.1M
Q2 24
$28.0M
$23.5M
Q1 24
$20.2M
$21.6M
Net Profit
ATER
ATER
NKTR
NKTR
Q4 25
$-7.9M
$-36.1M
Q3 25
$-2.3M
$-35.5M
Q2 25
$-4.9M
$-41.6M
Q1 25
$-3.9M
$-50.9M
Q4 24
$-1.3M
$7.3M
Q3 24
$-1.8M
$-37.1M
Q2 24
$-3.6M
$-52.4M
Q1 24
$-5.2M
$-36.8M
Gross Margin
ATER
ATER
NKTR
NKTR
Q4 25
56.1%
Q3 25
56.1%
Q2 25
54.3%
Q1 25
61.4%
Q4 24
63.4%
72.7%
Q3 24
60.3%
81.6%
Q2 24
60.4%
58.5%
Q1 24
65.1%
60.6%
Operating Margin
ATER
ATER
NKTR
NKTR
Q4 25
-51.1%
-126.9%
Q3 25
-10.7%
-268.6%
Q2 25
-23.1%
-324.2%
Q1 25
-24.1%
-425.8%
Q4 24
-6.5%
49.2%
Q3 24
-6.6%
-142.4%
Q2 24
-11.5%
-211.9%
Q1 24
-26.1%
-163.7%
Net Margin
ATER
ATER
NKTR
NKTR
Q4 25
-52.5%
-165.4%
Q3 25
-12.0%
-301.3%
Q2 25
-25.0%
-372.2%
Q1 25
-25.4%
-486.4%
Q4 24
-5.3%
24.9%
Q3 24
-6.8%
-153.6%
Q2 24
-13.0%
-222.9%
Q1 24
-25.5%
-170.1%
EPS (diluted)
ATER
ATER
NKTR
NKTR
Q4 25
$-4.67
Q3 25
$-1.87
Q2 25
$-2.95
Q1 25
$-0.24
Q4 24
$-2.07
Q3 24
$-2.66
Q2 24
$-3.76
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATER
ATER
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$4.9M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.2M
$89.8M
Total Assets
$29.6M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATER
ATER
NKTR
NKTR
Q4 25
$4.9M
$15.1M
Q3 25
$7.6M
$41.0M
Q2 25
$10.5M
$43.0M
Q1 25
$14.3M
$38.9M
Q4 24
$18.0M
$44.3M
Q3 24
$16.1M
$30.1M
Q2 24
$20.3M
$27.9M
Q1 24
$17.5M
$48.6M
Stockholders' Equity
ATER
ATER
NKTR
NKTR
Q4 25
$15.2M
$89.8M
Q3 25
$22.6M
$85.1M
Q2 25
$24.3M
$-24.2M
Q1 25
$27.0M
$13.7M
Q4 24
$30.0M
$60.7M
Q3 24
$30.6M
$48.9M
Q2 24
$30.9M
$79.7M
Q1 24
$33.0M
$126.7M
Total Assets
ATER
ATER
NKTR
NKTR
Q4 25
$29.6M
$280.4M
Q3 25
$40.1M
$301.3M
Q2 25
$45.4M
$207.5M
Q1 25
$49.8M
$256.2M
Q4 24
$49.5M
$303.9M
Q3 24
$52.1M
$308.0M
Q2 24
$59.9M
$343.3M
Q1 24
$55.7M
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATER
ATER
NKTR
NKTR
Operating Cash FlowLast quarter
$-1.0M
$-65.0M
Free Cash FlowOCF − Capex
$-1.0M
$-65.0M
FCF MarginFCF / Revenue
-6.9%
-298.0%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATER
ATER
NKTR
NKTR
Q4 25
$-1.0M
$-65.0M
Q3 25
$-1.6M
$-48.8M
Q2 25
$-4.4M
$-45.7M
Q1 25
$-3.9M
$-49.1M
Q4 24
$-9.0K
$-46.2M
Q3 24
$-722.0K
$-43.9M
Q2 24
$2.9M
$-37.7M
Q1 24
$-6.0K
$-47.9M
Free Cash Flow
ATER
ATER
NKTR
NKTR
Q4 25
$-1.0M
$-65.0M
Q3 25
$-1.6M
$-48.9M
Q2 25
$-4.4M
$-45.8M
Q1 25
$-49.1M
Q4 24
$-46.6M
Q3 24
$-44.6M
Q2 24
$2.9M
$-37.9M
Q1 24
$-42.0K
$-48.0M
FCF Margin
ATER
ATER
NKTR
NKTR
Q4 25
-6.9%
-298.0%
Q3 25
-8.4%
-414.5%
Q2 25
-22.7%
-409.6%
Q1 25
-469.0%
Q4 24
-159.9%
Q3 24
-184.9%
Q2 24
10.3%
-161.3%
Q1 24
-0.2%
-222.0%
Capex Intensity
ATER
ATER
NKTR
NKTR
Q4 25
0.0%
0.1%
Q3 25
0.2%
1.0%
Q2 25
0.0%
0.3%
Q1 25
0.0%
0.0%
Q4 24
0.0%
1.6%
Q3 24
0.0%
2.8%
Q2 24
0.0%
0.8%
Q1 24
0.2%
0.7%
Cash Conversion
ATER
ATER
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATER
ATER

Sales Channel Directly To Consumer$13.1M87%
Heating Cooling And Air Quality$2.1M14%

NKTR
NKTR

Segment breakdown not available.

Related Comparisons